Similar to lupus-prone B6.TC/Rab4AQ72L mice, flow cytometry of SLE and control participants, who had been matched for age and gender in the context of a clinical trial15, unveiled an expansion of CD98+ DN T cells in SLE patients (Fig. 9A, B). Here, SLC3A2 is linked to systemic lupus erythematosus.